~~<i id='B8C73F5D65'><strike id='B8C73F5D65'><tt id='B8C73F5D65'><pre id='B8C73F5D65'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：comprehensive 2025-09-28 05:12:42 Page View：1667

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Pharma needs to include young adults in clinical research
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

comprehensive

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

Asbestos ban is immediate, but health effects will linger for decades

BrookMitchell/GettyImagesAnewruleannouncedbytheEnvironmentalProtectionAgencythisweekputsanendtotheus

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Adam's Take: Intra

MollyFerguson/STATIamoneweekawayfromthelaunchofmyweeklyemailnewsletter!It’scalledAdam’sBiotechScorec